Schneider, U.; Leweke, F. M.; Weber, M. M.; Emrich, H. M.: Visual 3D illusion: a systems-theoretical approach to psychosis. European Archives of Psychiatry and Clinical Neuroscience 246, pp. 256 - 260 (1996)

Schreiber, W.; Lauer, C. J.; Krumrey, K.; Holsboer, F.; Krieg, J.-C.: Dysregulation of the hypothalamic-pituitary-adrenocortical system in panic disorder. Neuropsychopharmacology 15, pp. 7 - 15 (1996)

Schuster, P.; Wittchen, H.-U.: Ecstasy- und Hallozinogengebrauch bei Jugendlichen. Gibt es eine Zunahme? Verhaltenstherapie, Praxis-Forschung-Perspektiven 6, pp. 222 - 233 (1996)

Schwarz, J.; Trenkwalder, C.: Restless legs Syndrom: Therapie mit L-DOPA-Retardformen. Aktuelle Neurologie 23, pp. 26 - 29 (1996)

Seifritz, E.; Müller, M. J.; Trachsel, L.; Lauer, C. J.; Hemmeter, U.; Hatzinger, M.; Moore, P.; Holsboer-Trachsler, E.: Revisiting the Ehlers and Kupfer hypothesis: The growth hormone cortisol secretion ratio during sleep is correlated with electroencephalographic slow wave activity in normal volunteers. Biological Psychiatry 39, pp. 139 - 142 (1996)

Shoaib, M.; Almeida, O. F. X.: Absence of tolerance to the aversive stimulus properties of ethanol following oral ethanol self-administration. Alcohol 13, pp. 175 - 180 (1996)

Sonntag, A.; Rothe, B.; Guldner, J.; Yassouridis, A.; Holsboer, F.; Steiger, A.: Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression. Depression 4, pp. 1 - 13 (1996)

Spanagel, R.: The influence of opioid antagonists on the discriminative stimulus effects of ethanol. Pharmacology, Biochemistry and Behavior 54, pp. 645 - 649 (1996)

Spanagel, R.; Hölter, S.; Allingham, K.; Landgraf, R.; Zieglgänsberger, W.: Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. European Journal of Pharmacology 305, pp. 39 - 44 (1996)

Spanagel, R.; Putzke, J.; Stefferl, A.; Schöbitz, B.; Zieglgänsberger, W.: Acamprosate and alcohol: II. Effects on alcohol withdrawal. European Journal of Pharmacology 305, pp. 45 - 50 (1996)

Spanagel, R.; Stöhr, T.; Barden, N.; Holsboer, F.: Morphine-induced locomotor and neurochemical stimulation is enhanced in transgenic mice with impaired glucocorticoid receptor function. Journal of Neuroendocrinology 8, pp. 93 - 97 (1996)

Spanagel, R.; Zieglgänsberger, W.: Sucht im Tiermodell: Wirksamkeit von Acamprosat. Nervenheilkunde 15, pp. 469 - 472 (1996)

Spanagel, R.; Zieglgänsberger, W.; Hundt, W.: Acamprosate and alcohol: III. Effects on alcohol discrimination. European Journal of Pharmacology 305, pp. 51 - 56 (1996)

Steiger, A.; Colla-Müller, M.; Frieboes, R.-M.; Guldner, J.; Murck, H.; Schier, T.: Die Rolle von Neuropeptiden in der normalen und gestörten Schlafregulation. Wiener Medizinische Wochenschrift 146, pp. 291 - 293 (1996)

Ströhle, A.; Richert, A.; Gutzmann, H.: Der Münchner Verbale Gedächtnistest in der Demenzfrühesterkennung. Zeitschrift für Gerontopsychologie- U.-Psychiatrie 8, pp. 55 - 64 (1996)

Ströhle, A.; Wiedemann, K.: Flumazenil attenuates the pituitary response to CRH in healthy males. European Neuropsychopharmacology 6, pp. 323 - 325 (1996)

Teschemacher, A.; Zeise, M. L.; Zieglgänsberger, W.: The corticosterone-induced decrease of inhibitory postsynaptic potentials in rat hippocampal pyramidal neurons in vitro depends on cytosolic factors. Neuroscience Letters 215, pp. 83 - 86 (1996)

Toulmond, S.; Parnet, P.; Linthorst, A. C. E.: When cytokines get on your nerves: cytokine networks and CNS pathologies. Trends in Neurosciences 19, pp. 409 - 410 (1996)

Trachsel, L.; Dodt, H.-U.; Zieglgänsberger, W.: The intrinsic optical signal evoked by chiasm-stimulation in rat suprachiasmatic nuclei exhibits a GABAergic day night variation. European Journal of Neuroscience 8, pp. 319 - 328 (1996)

Trapp, T.; Holsboer, F.: Nuclear orphan receptor as a repressor of glucocorticoid receptor transcriptional activity. The Journal of Biological Chemistry 271, pp. 9879 - 9882 (1996)